Actively Recruiting
Cardiovascular and Endothelial Markers During OGTT Before and at Six and Twelve Months Post-treatment in Women With PCOS
Led by Attikon Hospital · Updated on 2025-11-19
120
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of the present study is to investigate a) the presence of subclinical markers of vascular, myocardial and endothelial function in women with PCOS b) the acute alterations in these markers during the oral glucose tolerance test (OGTT) c) the impact of potential treatment interventions in these markers.
CONDITIONS
Official Title
Cardiovascular and Endothelial Markers During OGTT Before and at Six and Twelve Months Post-treatment in Women With PCOS
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age over 16 years
- Diagnosis of PCOS by Rotterdam criteria with at least two of: clinical or biochemical hyperandrogenism, anovulation or oligo-ovulation, polycystic ovarian morphology
- No PCOS treatment in the past six months
- Ability to understand and sign the consent form
You will not qualify if you...
- Conditions similar to PCOS such as thyroid disease, hyperprolactinemia, non-classic congenital adrenal hyperplasia, Cushing syndrome, or acromegaly
- Current treatment with contraceptives or metformin
- Type 2 diabetes mellitus
- Diabetes treatment
- Pregnancy
- Lactation
- Malignancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Attikon University General Hospital
Chaïdári, Greece, 124 62
Actively Recruiting
Research Team
V
VAIA lAMBADIARI, Professor
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here